Many interested parties are keeping an eye on the development of LIB-01, Dicot's drug candidate for the treatment of erectile dysfunction, and the interest only seem to increase. At least if you ask the company's CEO,
Read the full article at biostock.se:
https://www.biostock.se/en/2023/11/great-interest-in-dicots-lib-01/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
https://news.cision.com/dicot-ab--publ-/r/biostock--great-interest-in-dicot-s-lib-01,c3884794
(c) 2023 Cision. All rights reserved., source